( August 11, 2026, 20:44 GMT | Official Statement) -- MLex Summary: A US judge has issued an order laying out how a hearing in which Takeda Pharmaceuticals and end-payor plaintiffs will present evidence and arguments over possible adjustments to damages calculations for overcharges plaintiffs paid for Amitiza will take place. Takeda seeks reductions of those damages based on rebates, subsidies, reimbursements, and other payments the EPPs received in connection with their Amitiza purchases, and "EPPs bear the initial and ultimate burden of establishing their actual damages, including accounting for any offsets they concede apply or establishing that no such offsets apply," the order filed in the District of Massachusetts said.Text entry follows: ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.